Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Negotiations between Altana and Hyal for licensing Solarase terminated

Oct. 19, 1998

Access signs agreement for amlexanox distribution in four additional markets

Oct. 19, 1998

Successful completion of human safety trials reported for VIMRx wound-healing agent

Oct. 14, 1998

Access signs more agreements for distribution of amlexanox

Oct. 14, 1998

More data reported for ADCON-P; FDA okays pivotal trial

Oct. 14, 1998

Demegen's Peptidyl MIM compound D4B effectively treats infected wounds

Oct. 13, 1998

Xoma completes phase II enrollment in psoriasis study

Oct. 13, 1998

Bristol-Myers Squibb and Unilever enter collaborative agreement for hair loss research

Oct. 9, 1998

Nonpeptide BK antagonist effective in guinea pig models of allergy

Oct. 7, 1998

Thalomid now available for prescribing in U.S.

Oct. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...